Sugiyama A - Search Results

1

Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo.

Matsukura S, Nakamura Y, Cao X, Wada T, Izumi-Nakaseko H, Ando K, Sugiyama A. Matsukura S, et al. Among authors: sugiyama a. Cardiovasc Toxicol. 2017 Apr;17(2):157-162. doi: 10.1007/s12012-016-9369-8. Cardiovasc Toxicol. 2017. PMID: 27040813

2

Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring.

Sugiyama A, Aye NN, Katahira S, Saitoh M, Hagihara A, Matsubara Y, Hashimoto K. Sugiyama A, et al. Toxicol Appl Pharmacol. 1997 Mar;143(1):89-95. doi: 10.1006/taap.1996.8061. Toxicol Appl Pharmacol. 1997. PMID: 9073596

3

Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.

Sugiyama A, Takahara A, Hashimoto K. Sugiyama A, et al. J Cardiovasc Pharmacol. 1999 Jul;34(1):70-7. doi: 10.1097/00005344-199907000-00012. J Cardiovasc Pharmacol. 1999. PMID: 10413070

4

Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.

Chiba K, Sugiyama A, Satoh Y, Shiina H, Hashimoto K. Chiba K, et al. Among authors: sugiyama a. Toxicol Appl Pharmacol. 2000 Nov 15;169(1):8-16. doi: 10.1006/taap.2000.9041. Toxicol Appl Pharmacol. 2000. PMID: 11076691

5

In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol.

Sugiyama A, Satoh Y, Hashimoto K. Sugiyama A, et al. Toxicol Appl Pharmacol. 2001 Jun 1;173(2):120-8. doi: 10.1006/taap.2001.9168. Toxicol Appl Pharmacol. 2001. PMID: 11384214

6

Electropharmacologic effects of a new phosphodiesterase III inhibitor, toborinone (OPC-18790), assessed in an in vivo canine model.

Sugiyama A, Satoh Y, Hashimoto K. Sugiyama A, et al. J Cardiovasc Pharmacol. 2001 Aug;38(2):268-77. doi: 10.1097/00005344-200108000-00013. J Cardiovasc Pharmacol. 2001. PMID: 11483877

7

Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model.

Sugiyama A, Satoh Y, Hashimoto K. Sugiyama A, et al. Jpn J Pharmacol. 2001 Sep;87(1):74-82. doi: 10.1254/jjp.87.74. Jpn J Pharmacol. 2001. PMID: 11676202 Free article.

8

Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs.

Sugiyama A, Satoh Y, Shiina H, Takahara A, Yoneyama M, Hashimoto K. Sugiyama A, et al. J Cardiovasc Pharmacol. 2001 Dec;38(6):940-6. doi: 10.1097/00005344-200112000-00016. J Cardiovasc Pharmacol. 2001. PMID: 11707698

9

Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models.

Sugiyama A, Satoh Y, Shiina H, Takeda S, Hashimoto K. Sugiyama A, et al. J Cardiovasc Pharmacol. 2002 Aug;40(2):235-45. doi: 10.1097/00005344-200208000-00009. J Cardiovasc Pharmacol. 2002. PMID: 12131553

10

Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.

Yoshida H, Sugiyama A, Satoh Y, Ishida Y, Yoneyama M, Kugiyama K, Hashimoto K. Yoshida H, et al. Among authors: sugiyama a. Circ J. 2002 Aug;66(8):758-62. doi: 10.1253/circj.66.758. Circ J. 2002. PMID: 12197602 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,142 results

Search Page

Filters